Chronic bronchitis is one of the two main types of chronic obstructive lung disease (COPD). The other is emphysema. Most people with COPD have symptoms of both conditions. In chronic bronchitis, ...

We use cookies to provide our services and for analytics and marketing. To find out more about our use of cookies and how you can disable them, please see our Privacy ...

Chronic kidney failure, or end-stage kidney disease (ESKD), occurs when the kidneys no longer function effectively and cannot filter waste and extra fluid from the body. It is the fifth and final ...

Another way to understand this secret is through the lens of chronic or toxic shame. If there is shame in your life, you are more likely to have anxiety or depression issues. Or, to put it another ...

This is particularly true for chronic diseases. For example, diabetes mellitus is defined biochemically according to the blood sugar concentration, cancer histologically according to the morphological ...

If action isn't taken now, Ontario's hospital system will not be able to cope with the influx of chronic illness cases in the next two decades, Anthony Dale, OHA president, told CBC Toronto.

“You're going to have patients that have short-term injuries that end up being chronic issues,” Marquita Lyons-Smith, a director in North Carolina Central University’s nursing ...

(Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology company developing long-acting anti-inflammatory therapies for the localized treatment of chronic rhinosinusitis ...

GSK an­nounced an­oth­er batch of pos­i­tive da­ta from its res­pi­ra­to­ry pro­gram with the in­ves­ti­ga­tion­al drug de­pemokimab, this time in pa­tients with chron­ic rhi ...

(IN BRIEF) GSK plc has announced positive results from its Phase III ANCHOR trials for depemokimab, a biologic treatment for chronic rhinosinusitis with nasal polyps (CRSwNP). The trials demonstrated ...

GSK Says Depemokimab For Chronic Rhinosinusitis Reduces Nasal Polyp Size, Nasal Obstruction Versus Placebo At One Year Vandana Singh Mon, Oct 14, 2024, 5:39 AM 2 min read ...

Chronic rhinosinusitis with nasal polyps has caught the attention of drugmakers since U.S. approval of Sanofi and Regeneron Pharmaceuticals’ Dupixent in 2019. Abbreviated as CRSwNP, the condition ...